Tislelizumab-jsgr (Tevimbra) was approved in combination with chemotherapy for the treatment of unresectable or metastatic ...

NBC News investigates health insurance companies denying cancer patients coverage for potentially life-saving treatments.

Health insurance company interference is rising, an NBC News investigation found. Doctors say the stakes are highest in ...

The FDA approved subcutaneous nivolumab for solid tumors, tiselizumab for advanced gastric and GEJ cancers, and key 2024 breast cancer breakthroughs are reviewed. Experts provide perspective on ...

Tevimbra is already approved in the US for the treatment of unresectable or metastatic oesophageal squamous cell carcinoma ...

San Mateo, California Monday, December 30, 2024, 18:00 Hrs [IST] ...

Former West Ham goalkeeper Ludek Miklosko has announced he is ceasing treatment for stomach cancer because he does not wish ...

Tevimbra is also approved in the U.S. as monotherapy for the treatment of adult patients with unresectable or metastatic esophageal squamous cell carcinoma after prior systemic chemotherapy that doesn ...

Testing showed Roberts had “quite advanced” cancer in the lower part of her stomach - she had no symptoms. “It was a shock ...

The Food and Drug Administration (FDA) has approved Tevimbra (tislelizumab-jsgr) in combination with platinum and ...

Discover how ctDNA methylation biomarkers enhance gastric cancer monitoring, providing a non-invasive method for prognosis ...